innate pharma 产品代理
innate pharma 产品代理
Innate Pharma 广泛的抗体产品线包括几种潜在的一流临床和临床前候选药物，用于治疗医疗需求未得到满足的癌症。
Innate 是了解自然杀伤细胞 (NK 细胞) 生物学的先驱，并扩展了其在肿瘤微环境和肿瘤抗原以及抗体工程方面的专业知识。 这种创新方法导致了多元化的专有产品组合和与生物制药行业领先者的主要联盟，包括 Bristol-Myers Squibb Novo Nordisk A/S、Sanofi，以及与 AstraZeneca 的多产品合作。
Innate Pharma 总部位于法国马赛，在巴黎泛欧交易所和美国纳斯达克上市。
Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.
Innate is a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.
Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.
